menu search

Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023

Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023
SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it will present at the Oxford Global Immuno US 2023, to be held on October 12-13, 2023 in San Diego, CA. Thierry Guillaudeux, […] The post Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023 appeared first on ForexTV... Read More
Posted: Oct 9 2023, 16:10
Author Name: forextv
Views: 112561

Search within

Pages Search Results: